Hamlet BioPharma AB publ

NEW
XSAT:HAMLET B (Sweden)   Ordinary Shares - Class B
kr 6.67 -0.13 (-1.91%) Aug 17
At Loss
P/B:
34.56
Market Cap:
kr 1.27B ($ 133.18M)
Enterprise V:
kr 1.26B ($ 131.71M)
Volume:
76.00K
Avg Vol (2M):
92.82K
Trade In:
Volume:
76.00K
At Loss
Avg Vol (2M):
92.82K

Hamlet BioPharma AB publ (XSAT:HAMLET B) Dividend

Hamlet BioPharma AB publ (XSAT:HAMLET B) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -15.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: XSAT:HAMLET B Dividend

Does Hamlet BioPharma AB publ (XSAT:HAMLET B) pay a dividend?

Hamlet BioPharma AB publ (XSAT:HAMLET B) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Hamlet BioPharma AB publ pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Hamlet BioPharma AB publ has returned capital to shareholders via buybacks at a rate of -15.6% over the past 3 years.

What are dividend-paying alternatives to Hamlet BioPharma AB publ?

For dividend-paying alternatives in Hamlet BioPharma AB publ's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.